114 related articles for article (PubMed ID: 38662960)
1. Combination of Chemical and Physical Cancer Therapeutics Developed with Microcapsules Made of κ-Casein and Gold Nanoparticles in the Presence of Drug-Loaded Phase Change Materials.
Ha Y; An S; Paik SR
ACS Appl Mater Interfaces; 2024 Apr; ():. PubMed ID: 38662960
[TBL] [Abstract][Full Text] [Related]
2. Fabrication of Protease-Sensitive and Light-Responsive Microcapsules Encompassed with Single Layer of Gold Nanoparticles by Using Self-Assembly Protein of α-Synuclein.
Hong CS; Park JH; Lee S; Rhoo KY; Lee JT; Paik SR
ACS Appl Mater Interfaces; 2018 Aug; 10(31):26628-26640. PubMed ID: 30052414
[TBL] [Abstract][Full Text] [Related]
3. Multifactorial drug carrier system bringing both chemical and physical therapeutics to the treatment of tumor heterogeneity.
Nam EJ; Cho I; Park H; Paik SR
J Control Release; 2024 May; 369():101-113. PubMed ID: 38508524
[TBL] [Abstract][Full Text] [Related]
4. Investigation of Eutectic Mixtures of Fatty Acids as a Novel Construct for Temperature-Responsive Drug Delivery.
Parveen F; Madni A; Torchilin VP; Rehman M; Jamshaid T; Filipczak N; Rai N; Khan MM; Khan MI
Int J Nanomedicine; 2022; 17():2413-2434. PubMed ID: 35656165
[TBL] [Abstract][Full Text] [Related]
5. A new NIR-triggered doxorubicin and photosensitizer indocyanine green co-delivery system for enhanced multidrug resistant cancer treatment through simultaneous chemo/photothermal/photodynamic therapy.
Yu Y; Zhang Z; Wang Y; Zhu H; Li F; Shen Y; Guo S
Acta Biomater; 2017 Sep; 59():170-180. PubMed ID: 28629893
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional phase-change hollow mesoporous Prussian blue nanoparticles as a NIR light responsive drug co-delivery system to overcome cancer therapeutic resistance.
Chen H; Ma Y; Wang X; Zha Z
J Mater Chem B; 2017 Sep; 5(34):7051-7058. PubMed ID: 32263896
[TBL] [Abstract][Full Text] [Related]
7. Thermosensitive drug-loading system based on copper sulfide nanoparticles for combined photothermal therapy and chemotherapy in vivo.
Yuan Z; Qu S; He Y; Xu Y; Liang L; Zhou X; Gui L; Gu Y; Chen H
Biomater Sci; 2018 Nov; 6(12):3219-3230. PubMed ID: 30255863
[TBL] [Abstract][Full Text] [Related]
8. A multi-controlled drug delivery system based on magnetic mesoporous Fe
Zhang Q; Liu J; Yuan K; Zhang Z; Zhang X; Fang X
Nanotechnology; 2017 Oct; 28(40):405101. PubMed ID: 28837053
[TBL] [Abstract][Full Text] [Related]
9. NIR-triggered release of DOX from sophorolipid-coated mesoporous carbon nanoparticles with the phase-change material 1-tetradecanol to treat MCF-7/ADR cells.
Hussain A; Guo S
J Mater Chem B; 2019 Feb; 7(6):974-985. PubMed ID: 32255102
[TBL] [Abstract][Full Text] [Related]
10. High-stabilized polydopamine modified low eutectic fatty acids based on near-infrared response for breast cancer therapy.
Ma Y; Qian C; Ma L; Guo P; Sun S; Zhang L; Zhang F; Yang D
J Photochem Photobiol B; 2021 Jul; 220():112213. PubMed ID: 34023596
[TBL] [Abstract][Full Text] [Related]
11. A Eutectic Mixture of Natural Fatty Acids Can Serve as the Gating Material for Near-Infrared-Triggered Drug Release.
Zhu C; Huo D; Chen Q; Xue J; Shen S; Xia Y
Adv Mater; 2017 Oct; 29(40):. PubMed ID: 28873241
[TBL] [Abstract][Full Text] [Related]
12. Continuous processing of phase-change materials into uniform nanoparticles for near-infrared-triggered drug release.
Chen Q; Zhu C; Huo D; Xue J; Cheng H; Guan B; Xia Y
Nanoscale; 2018 Dec; 10(47):22312-22318. PubMed ID: 30467567
[TBL] [Abstract][Full Text] [Related]
13. A 2D nanotheranostic platform based on graphene oxide and phase-change materials for bimodal CT/MR imaging, NIR-activated drug release, and synergistic thermo-chemotherapy.
Mirrahimi M; Alamzadeh Z; Beik J; Sarikhani A; Mousavi M; Irajirad R; Khani T; Davani ES; Farashahi A; Ardakani TS; Bulte JWM; Ghaznavi H; Shakeri-Zadeh A
Nanotheranostics; 2022; 6(4):350-364. PubMed ID: 35707061
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin-loaded oligonucleotide conjugated gold nanoparticles: A promising in vivo drug delivery system for colorectal cancer therapy.
Lee CS; Kim H; Yu J; Yu SH; Ban S; Oh S; Jeong D; Im J; Baek MJ; Kim TH
Eur J Med Chem; 2017 Dec; 142():416-423. PubMed ID: 28870452
[TBL] [Abstract][Full Text] [Related]
15. The effective nuclear delivery of doxorubicin from dextran-coated gold nanoparticles larger than nuclear pores.
Jang H; Ryoo SR; Kostarelos K; Han SW; Min DH
Biomaterials; 2013 Apr; 34(13):3503-10. PubMed ID: 23395274
[TBL] [Abstract][Full Text] [Related]
16. The comparative effect of wrapping solid gold nanoparticles and hollow gold nanoparticles with doxorubicin-loaded thermosensitive liposomes for cancer thermo-chemotherapy.
Li Y; He D; Tu J; Wang R; Zu C; Chen Y; Yang W; Shi D; Webster TJ; Shen Y
Nanoscale; 2018 May; 10(18):8628-8641. PubMed ID: 29697100
[TBL] [Abstract][Full Text] [Related]
17. Phase-Change Material Packaged within Hollow Copper Sulfide Nanoparticles Carrying Doxorubicin and Chlorin e6 for Fluorescence-Guided Trimodal Therapy of Cancer.
Li Q; Sun L; Hou M; Chen Q; Yang R; Zhang L; Xu Z; Kang Y; Xue P
ACS Appl Mater Interfaces; 2019 Jan; 11(1):417-429. PubMed ID: 30537815
[TBL] [Abstract][Full Text] [Related]
18. Multifunctional mesoporous ZrO
Feng L; Gai S; He F; Dai Y; Zhong C; Yang P; Lin J
Biomaterials; 2017 Dec; 147():39-52. PubMed ID: 28926732
[TBL] [Abstract][Full Text] [Related]
19. Co-delivery of 5-fluorodeoxyuridine and doxorubicin via gold nanoparticle equipped with affibody-DNA hybrid strands for targeted synergistic chemotherapy of HER2 overexpressing breast cancer.
Zhang C; Zhang F; Han M; Wang X; Du J; Zhang H; Li W
Sci Rep; 2020 Dec; 10(1):22015. PubMed ID: 33328545
[TBL] [Abstract][Full Text] [Related]
20. Porphyran capped gold nanoparticles as a novel carrier for delivery of anticancer drug: in vitro cytotoxicity study.
Venkatpurwar V; Shiras A; Pokharkar V
Int J Pharm; 2011 May; 409(1-2):314-20. PubMed ID: 21376108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
